Adenosine A2A receptors, dopamine D2 receptors and their interactions in Parkinson's disease

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Movement Disorders

• Publication date

  2007-10-31

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/mds.21440
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Adenosine A2A and dopamine D2 heteromeric receptor complexes and their function

  2007cited by this paper
• Biochemical identification of the dopamine D2 receptor domains interacting with the adenosine A2A receptor

  2007cited by this paper
• Journal of Neuroinflammation BioMed Central

  2007cited by this paper
• Receptor-receptor interactions, receptor mosaics, and basic principles of molecular network organization

  2007cited by this paper
• Computer-assisted image analysis of caveolin-1 involvement in the internalization process of adenosine A2A-dopamine D2 receptor heterodimers

  2007cited by this paper
• Role of electrostatic interaction in receptor-receptor heteromerization

  2007cited by this paper
• The specificity and molecular basis of α1-adrenoceptor and CXCR chemokine receptor dimerization

  2007cited by this paper
• Summary of wenner-gren international symposium receptor-receptor interactions among heptaspanning membrane receptors: From structure to function

  2007cited by this paper
• Striatal plasticity in parkinsonism: dystrophic changes in medium spiny neurons and progression in Parkinson's disease.

  2006cited by this paper
• Mouse spinal cord compression injury is reduced by either activation of the adenosine A2A receptor on bone marrow-derived cells or deletion of the A2A receptor on non-bone marrow-derived cells.

  2006cited by this paper
• Presynaptic Control of Striatal Glutamatergic Neurotransmission by Adenosine A1–A2A Receptor Heteromers

  2006cited by this paper
• A boolean network modelling of receptor mosaics relevance of topology and cooperativity

  2006cited by this paper
• Experimental studies and theoretical aspects on A2A/D2 receptor interactions in a model of Parkinson's disease. Relevance for L-dopa induced dyskinesias.

  2006cited by this paper
• The nigrostriatal DA pathway and Parkinson's disease.

  2006cited by this paper
• Dopamine in neurotoxicity and neuroprotection: what do D2 receptors have to do with it?

  2006cited by this paper
• Targeting adenosine A2A receptors in Parkinson's disease.

  2006cited by this paper
• Reversion of levodopa‐induced motor fluctuations by the A2A antagonist CSC is associated with an increase in striatal preprodynorphin mRNA expression in 6‐OHDA‐lesioned rats

  2006cited by this paper
• Selective elimination of glutamatergic synapses on striatopallidal neurons in Parkinson disease models

  2006cited by this paper
• D2 dopamine receptor-induced sensitization of adenylyl cyclase type 1 is G alpha(s) independent.

  2006cited by this paper
• Actions of adenosine at its receptors in the CNS: insights from knockouts and drugs.

  2005cited by this paper
• Adenosine A2A Receptor and Dopamine D3 Receptor Interactions: Evidence of Functional A2A/D3 Heteromeric Complexes

  2005cited by this paper
• Dopamine D3 receptor antagonists as therapeutic agents.

  2005cited by this paper
• Dopamine D2 receptor stimulation of mitogen‐activated protein kinases mediated by cell type‐dependent transactivation of receptor tyrosine kinases

  2005cited by this paper
• Metabotropic glutamate receptors in the basal ganglia motor circuit

  2005cited by this paper
• KW-6002 protects from MPTP induced dopaminergic toxicity in the mouse.

  2005cited by this paper
• Activation of a novel PKC isoform synergistically enhances D2L dopamine receptor-mediated sensitization of adenylate cyclase type 6.

  2005cited by this paper
• Protection but maintained dysfunction of nigral dopaminergic nerve cell bodies and striatal dopaminergic terminals in MPTP-lesioned mice after acute treatment with the mGluR5 antagonist MPEP.

  2005cited by this paper
• Therapeutic potential of adenosine A(2A) receptor antagonists in Parkinson's disease.

  2005cited by this paper
• SupersensitiveΒ-adrenergic receptors are down-regulated in rat brain by mianserin administration

  2005cited by this paper
• Adenosine in Tissue Protection and Tissue Regeneration

  2005cited by this paper
• Co‐localization and functional interaction between adenosine A2A and metabotropic group 5 receptors in glutamatergic nerve terminals of the rat striatum

  2005cited by this paper
• Interactions between Metabotropic Glutamate 5 and Adenosine A2A Receptors in Normal and Parkinsonian Mice

  2005cited by this paper
• Impact of time-dependent changes in spine density and spine shape on the input-output properties of a dendritic branch: a computational study.

  2005cited by this paper
• Protein-Protein Coupling/Uncoupling Enables Dopamine D2 Receptor Regulation of AMPA Receptor-Mediated Excitotoxicity

  2005cited by this paper
• Pharmacological validation of a mouse model of l-DOPA-induced dyskinesia.

  2005cited by this paper
• Distribution and origin of calcitonin gene-related peptide in the rat stomach and duodenum: An immunocytochemical analysis

  2005cited by this paper
• Parkinson-like syndrome induced by continuous MPTP infusion: convergent roles of the ubiquitin-proteasome system and alpha-synuclein.

  2005cited by this paper
• Striatal plasticity at the network level. Focus on adenosine A2A and D2 interactions in models of Parkinson's Disease.

  2004cited by this paper
• G Protein-Coupled Receptor Dimerization: Function and Ligand Pharmacology

  2004cited by this paper
• Sensitization of Neuronal A2A Adenosine Receptors after Persistent D2 Dopamine Receptor Activation

  2004cited by this paper
• Striatal plasticity and extrapyramidal motor dysfunction.

  2004cited by this paper
• Upregulation of striatal adenosine A2A receptor mRNA in 6‐hydroxydopamine‐lesioned rats intermittently treated with L‐DOPA

  2004cited by this paper
• Multiple Interactions between Transmembrane Helices Generate the Oligomeric α1b-Adrenoceptor

  2004cited by this paper
• Translating Adenosine A2A Receptor Biology into Novel Therapies for Parkinson’s Disease

  2004cited by this paper
• The role of dopamine D3 compared with D2 receptors in the control of locomotor activity: a combined behavioural and neurochemical analysis with novel, selective antagonists in rats

  2004cited by this paper
• Increased adenosine A2A receptors in the brain of Parkinson's disease patients with dyskinesias.

  2004cited by this paper
• Selective blockade of D(3) dopamine receptors enhances the anti-parkinsonian properties of ropinirole and levodopa in the MPTP-lesioned primate.

  2004cited by this paper
• On the Molecular Basis of the Receptor Mosaic Hypothesis of the Engram

  2004cited by this paper
• Combining mass spectrometry and pull-down techniques for the study of receptor heteromerization. Direct epitope-epitope electrostatic interactions between adenosine A2A and dopamine D2 receptors.

  2004cited by this paper
• Dopamine receptor agonists in the therapy of Parkinson’s disease

  2004cited by this paper
• DARPP-32 and modulation of cAMP signaling: involvement in motor control and levodopa-induced dyskinesia.

  2004cited by this paper
• Simultaneous Blockade of Adenosine A2A and Metabotropic Glutamate mGlu5 Receptors Increase their Efficacy in Reversing Parkinsonian Deficits in Rats

  2004cited by this paper
• Blockade of adenosine A2A receptors antagonizes parkinsonian tremor in the rat tacrine model by an action on specific striatal regions.

  2004cited by this paper
• Selective inactivation or reconstitution of adenosine A2A receptors in bone marrow cells reveals their significant contribution to the development of ischemic brain injury

  2004cited by this paper
• Adenosine A2A-dopamine D2 receptor-receptor heteromers. Targets for neuro-psychiatric disorders.

  2004cited by this paper
• Endogenous Activation of mGlu5 Metabotropic Glutamate Receptors Contributes to the Development of Nigro-Striatal Damage Induced by 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine in Mice

  2004cited by this paper
• Adenosine A2A receptor antagonism and neuroprotection: mechanisms, lights, and shadows.

  2004cited by this paper
• Neuroprotective effect of L-DOPA co-administered with the adenosine A2A receptor agonist CGS 21680 in an animal model of Parkinson's disease.

  2004cited by this paper
• Adenosine A2A and dopamine receptor interactions in basal ganglia of dopamine denervated rats

  2003cited by this paper
• Genetic and pharmacological inactivation of the adenosine A2A receptor attenuates 3‐nitropropionic acid‐induced striatal damage

  2003cited by this paper
• Adenosine A2A receptor antagonist treatment of Parkinson’s disease

  2003cited by this paper
• Oligomerization of adenosine A2A and dopamine D2 receptors in living cells.

  2003cited by this paper
• A Dual Role of Adenosine A2A Receptors in 3-Nitropropionic Acid-Induced Striatal Lesions: Implications for the Neuroprotective Potential of A2A Antagonists

  2003cited by this paper
• Adenosinergic Protection of Dopaminergic and GABAergic Neurons against Mitochondrial Inhibition through Receptors Located in the Substantia Nigra and Striatum, Respectively

  2003cited by this paper
• Adenosine receptors and Huntington's disease: implications for pathogenesis and therapeutics.

  2003cited by this paper
• Homodimerization of adenosine A2A receptors: qualitative and quantitative assessment by fluorescence and bioluminescence energy transfer

  2003cited by this paper
• Loss of bidirectional striatal synaptic plasticity in L-DOPA–induced dyskinesia

  2003cited by this paper
• Randomized trial of the adenosine A2A receptor antagonist istradefylline in advanced PD

  2003cited by this paper
• Possible role of intramembrane receptor-receptor interactions in memory and learning via formation of long-lived heteromeric complexes: focus on motor learning in the basal ganglia.

  2003cited by this paper
• On the Nested Hierarchical Organization of CNS: Basic Characteristics of Neuronal Molecular Networks

  2003cited by this paper
• Behavioral effects of dopamine agonists and antagonists in MPTP-lesioned D3 receptor knockout mice.

  2003cited by this paper
• Potent activation of dopamine D3/D2 heterodimers by the antiparkinsonian agents, S32504, pramipexole and ropinirole

  2003cited by this paper
• A2A antagonist prevents dopamine agonist-induced motor complications in animal models of Parkinson's disease.

  2003cited by this paper
• The Human D2 Dopamine Receptor Synergizes with the A2A Adenosine Receptor to Stimulate Adenylyl Cyclase in PC12 Cells

  2003cited by this paper
• Metabotropic mGlu5 receptors regulate adenosine A2A receptor signaling

  2003cited by this paper
• Translating A2A antagonist KW6002 from animal models to parkinsonian patients

  2003cited by this paper
• Chronic activation of ERK and neurodegenerative diseases

  2003cited by this paper
• Adenosine A2A-Dopamine D2 Receptor-Receptor Heteromerization

  2003cited by this paper
• Molecular Mechanisms and Therapeutical Implications of Intramembrane Receptor/Receptor Interactions among Heptahelical Receptors with Examples from the Striatopallidal GABA Neurons

  2003cited by this paper
• The Scaling of White Matter to Gray Matter in Cerebellum and Neocortex

  2003cited by this paper
• Group I Metabotropic Glutamate Receptors in the Monkey Striatum: Subsynaptic Association with Glutamatergic and Dopaminergic Afferents

  2003cited by this paper
• Neuroprotection by caffeine and adenosine A2A receptor blockade of β‐amyloid neurotoxicity

  2003cited by this paper
• Receptor heteromerization in adenosine A2A receptor signaling

  2003cited by this paper
• Adenosine A(2A) receptor antagonist treatment of Parkinson's disease.

  2003cited by this paper
• Adenosine A2A receptors in neuroadaptation to repeated dopaminergic stimulation

  2003cited by this paper
• Translating Adenosine A24 Receptor Biology into Novel Therapies for Parkinson's Disease

  2002cited by this paper
• MPP+ increases α-synuclein expression and ERK/MAP-kinase phosphorylation in human neuroblastoma SH-SY5Y cells

  2002cited by this paper
• Neuroprotection by adenosine A2A receptor blockade in experimental models of Parkinson's disease

  2002cited by this paper
• Dopamine D4 receptors are heterogeneously distributed in the striosomes/matrix compartments of the striatum

  2002cited by this paper
• Adenosine A2A antagonism reverses levodopa‐induced motor alterations in hemiparkinsonian rats

  2002cited by this paper
• Protective effect of dopamine D2 agonists in cortical neurons via the phosphatidylinositol 3 kinase cascade

  2002cited by this paper
• Metabotropic glutamate mGlu5 receptor-mediated modulation of the ventral striopallidal GABA pathway in rats. Interactions with adenosine A(2A) and dopamine D(2) receptors.

  2002cited by this paper
• Coaggregation, Cointernalization, and Codesensitization of Adenosine A2A Receptors and Dopamine D2Receptors*

  2002cited by this paper
• Blockade of Striatal Adenosine A2A Receptor Reduces, through a Presynaptic Mechanism, Quinolinic Acid-Induced Excitotoxicity: Possible Relevance to Neuroprotective Interventions in Neurodegenerative Diseases of the Striatum

  2002cited by this paper
• Persistent Behavioral Sensitization to Chronic l-DOPA Requires A2A Adenosine Receptors

  2002cited by this paper
• Impaired D2 Dopamine Receptor Function in Mice Lacking Type 5 Adenylyl Cyclase

  2002cited by this paper
• Molecular mechanisms for heterologous sensitization of adenylate cyclase.

  2002cited by this paper
• Synergistic interaction between adenosine A2A and glutamate mGlu5 receptors: Implications for striatal neuronal function

  2002cited by this paper
• Cytoplasmic aggregates of phosphorylated extracellular signal-regulated protein kinases in Lewy body diseases.

  2002cited by this paper
• Adenosine A2A agonist reduces paralysis after spinal cord ischemia: correlation with A2A receptor expression on motor neurons.

  2002cited by this paper

• Neurochemical imaging reveals changes in dopamine dynamics with photoperiod in a seasonally social vole species.

  2026cites this paper
• Neurochemical imaging reveals changes in dopamine dynamics with photoperiod in a seasonally social vole species

  2025cites this paper
• Management of freezing of gait — mechanism-based practical recommendations

  2025cites this paper
• Accurate Neurotransmitter Release by Ultrasound‐Responsive Nanomaterials for Alleviating L‐DOPA‐Induced Dyskinesia in Parkinson's Disease

  2025cites this paper
• Possible roles of heteroreceptor complexes in excitotoxic processes

  2024cites this paper
• Analysis of ADORA2A, MTA1, PTGDS, PTGS2, NSF, and HNMT Gene Expression Levels in Peripheral Blood of Patients with Early Stages of Parkinson's Disease

  2023cites this paper
• Receptor-receptor interactions and microvesicle exchange as mechanisms modulating signaling between neurons and astrocytes.

  2023cites this paper
• Topography and distribution of adenosine A2A and dopamine D2 receptors in the human Subthalamic Nucleus

  2022cites this paper
• Therapeutic potential of targeting G protein-gated inwardly rectifying potassium (GIRK) channels in the central nervous system.

  2021cites this paper
• Functional neuroanatomy of the basal ganglia

  2021cites this paper
• A Potential Interface between the Kynurenine Pathway and Autonomic Imbalance in Schizophrenia

  2021cites this paper
• Evidence for Protein–Protein Interaction between Dopamine Receptors and the G Protein-Coupled Receptor 143

  2021cites this paper
• Immunomodulatory Effects of Dopamine in Inflammatory Diseases

  2021cites this paper
• Development of 18F-Labeled Radiotracers for PET Imaging of the Adenosine A2A Receptor: Synthesis, Radiolabeling and Preliminary Biological Evaluation

  2021cites this paper
• Synthesis and Biological Evaluation of a Novel 18F-Labeled Radiotracer for PET Imaging of the Adenosine A2A Receptor

  2021cites this paper
• Enhanced GABAergic Inhibition of Cholinergic Interneurons in the zQ175+/− Mouse Model of Huntington's Disease

  2021cites this paper
• Adenosine A2A-dopamine D2 receptor-receptor interaction in neurons and astrocytes: Evidence and perspectives.

  2020cites this paper
• Activation of Astrocytes in the Dorsomedial Striatum Facilitates Transition From Habitual to Goal-Directed Reward-Seeking Behavior.

  2020cites this paper
• Distinct Dopamine D2 Receptor Antagonists Differentially Impact D2 Receptor Oligomerization

  2019cites this paper
• Understanding receptor heteromerization and its allosteric integration of signals.

  2019cites this paper
• Role of Adenosine A2A Receptors in the Central Fatigue of Neurodegenerative Diseases

  2019cites this paper
• Overlap in synaptic neurological condition susceptibility pathways and the neural pannexin 1 interactome revealed by bioinformatics analyses

  2019cites this paper
• Molecular Dynamics Simulations of Adenosine Receptors: Advances, Applications and Trends.

  2019cites this paper
• Purinergic Signalling in Parkinson’s Disease: A Multi-target System to Combat Neurodegeneration

  2019cites this paper
• MicroRNAs: Game Changers in the Regulation of α-Synuclein in Parkinson's Disease

  2019cites this paper
• A2A-D2 Heteromers on Striatal Astrocytes: Biochemical and Biophysical Evidence

  2019cites this paper
• Potentiation of cannabinoid signaling in microglia by adenosine A2A receptor antagonists

  2019cites this paper
• Adenosine heteroreceptor complexes in the basal ganglia are implicated in Parkinson’s disease and its treatment

  2019cites this paper
• Understanding the Role of Adenosine A2AR Heteroreceptor Complexes in Neurodegeneration and Neuroinflammation

  2018cites this paper
• The Role of Adenosine Receptors in Psychostimulant Addiction

  2018influential citation
• Adenosine Receptors as a Paradigm to Identify Dimer/Oligomers of G-Protein-Coupled Receptors and as Targets in Parkinson’s Disease and Schizophrenia

  2018cites this paper
• Homocysteine and A2A-D2 Receptor-Receptor Interaction at Striatal Astrocyte Processes

  2018cites this paper
• Mapping the Interface of a GPCR Dimer: A Structural Model of the A2A Adenosine and D2 Dopamine Receptor Heteromer

  2018cites this paper
• Identifying novel members of the Wntless interactome through genetic and candidate gene approaches.

  2017cites this paper
• Dopaminergic Regulation of Innate Immunity: a Review

  2017cites this paper
• Adenosine A1 and A2A Receptors in the Brain: Current Research and Their Role in Neurodegeneration

  2017cites this paper
• Striatal Gαolf/cAMP Signal-Dependent Mechanism to Generate Levodopa-Induced Dyskinesia in Parkinson’s Disease

  2017cites this paper
• Dopamine-Induced Changes in Gαolf Protein Levels in Striatonigral and Striatopallidal Medium Spiny Neurons Underlie the Genesis of l-DOPA-Induced Dyskinesia in Parkinsonian Mice

  2017cites this paper
• Angiotensin II type 1/adenosine A2A receptor oligomers: a novel target for tardive dyskinesia

  2017cites this paper
• Imidazo[1,2-α]pyridines possess adenosine A1 receptor affinity for the potential treatment of cognition in neurological disorders.

  2017cites this paper
• The synthesis and evaluation of imidazopyridines as adenosine receptor antagonists

  2017influential citation
• Heteroreceptor Complexes Implicated in Parkinson’s Disease

  2017cites this paper
• Probing Self-Assembly of G Protein-Coupled Receptor Oligomers in Membranes Using Molecular Dynamics Modeling and Experimental Approaches

  2017cites this paper
• Endocannabinoid-Dependent Synaptic Plasticity in the Striatum

  2017cites this paper
• Neurotransmission systems in Parkinson’s disease

  2017cites this paper
• Interplay of G Protein-Coupled Receptors with the Membrane: Insights from Supra-Atomic Coarse Grain Molecular Dynamics Simulations.

  2017cites this paper
• Striatal adenosine–cannabinoid receptor interactions in rats over‐expressing adenosine A2A receptors

  2016cites this paper
• Telocytes in their context with other intercellular communication agents.

  2016cites this paper
• G-Protein-Coupled Receptors Heterodimers and Receptor Mosaics of Different Types of

  2016cites this paper
• Purinergic signaling in Parkinson's disease. Relevance for treatment.

  2016cites this paper
• Are the Symptoms of Parkinsonism Cortical in Origin?☆☆☆

  2016cites this paper
• 2‐Amino[1,2,4]triazolo[1,5‐c]quinazolines and Derived Novel Heterocycles: Syntheses and Structure–Activity Relationships of Potent Adenosine Receptor Antagonists

  2016cites this paper
• Membrane omega-3 fatty acids modulate the oligomerisation kinetics of adenosine A2A and dopamine D2 receptors

  2016cites this paper
• Review about the manganese speciation project related to neurodegeneration: An analytical chemistry approach to increase the knowledge about manganese related parkinsonian symptoms.

  2016cites this paper
• Small-Molecule Inhibitors of Protein–Protein Interactions

  2016cites this paper
• An Anti-Parkinson’s Disease Drug via Targeting Adenosine A2A Receptor Enhances Amyloid-β Generation and γ-Secretase Activity

  2016cites this paper
• Volume Transmission in Central Dopamine and Noradrenaline Neurons and Its Astroglial Targets

  2015cites this paper
• Changes in Brain Metallome/Metabolome Pattern due to a Single i.v. Injection of Manganese in Rats

  2015cites this paper
• On the Role of the Balance of GPCR Homo/ Heteroreceptor Complexes in the Brain

  2015cites this paper
• Dopamine receptors – IUPHAR Review 13

  2015cites this paper
• Purine metabolism gene deregulation in Parkinson's disease

  2015cites this paper
• Tea component, epigallocatechin gallate, potentiates anticataleptic and locomotor-sensitizing effects of caffeine in mice.

  2015cites this paper
• G-protein-coupled receptor type A heteromers as an emerging therapeutic target

  2015cites this paper
• The role of transmitter diffusion and flow versus extracellular vesicles in volume transmission in the brain neural–glial networks

  2015cites this paper
• NC-IUPHAR REVIEW Dopamine receptors - IUPHAR Review 13

  2015cites this paper
• Effects of distinct populations of adenosine receptors in the ventral striatum on cocaine seeking

  2015influential citation
• Comorbidities in Neurology: Is adenosine the common link?

  2015cites this paper
• The Effects of Coffee Consumption on Cognition and Dementia Diseases

  2015cites this paper
• Dopamine heteroreceptor complexes as therapeutic targets in Parkinson’s disease

  2015cites this paper
• of G-Protein-Coupled Receptors Heterodimers and Receptor Mosaics of Different Types

  2015cites this paper
• Diversity and Bias through Receptor–Receptor Interactions in GPCR Heteroreceptor Complexes. Focus on Examples from Dopamine D2 Receptor Heteromerization

  2014cites this paper
• Moonlighting Proteins and Protein–Protein Interactions as Neurotherapeutic Targets in the G Protein-Coupled Receptor Field

  2014influential citation
• On the role of A2A and D2 receptors in control of cocaine and food-seeking behaviors in rats

  2014cites this paper
• Effects of the selective adenosine A2A receptor antagonist, SCH 412348, on the parkinsonian phenotype of MitoPark mice.

  2014cites this paper
• Increased striatal adenosine A2A receptor levels is an early event in Parkinson's disease-related pathology and it is potentially regulated by miR-34b.

  2014cites this paper
• Modulation of neuroimmunity by adenosine and its receptors: metabolism to mental illness.

  2014cites this paper
• Dopamine D2 heteroreceptor complexes and their receptor-receptor interactions in ventral striatum: novel targets for antipsychotic drugs.

  2014cites this paper
• A2A adenosine receptors and Parkinson's disease severity

  2014cites this paper
• The impact of receptor–receptor interactions in heteroreceptor complexes on brain plasticity

  2014cites this paper
• Receptor-receptor interactions in heteroreceptor complexes: a new principle in biology. Focus on their role in learning and memory

  2014cites this paper
• L-DOPA-induced behavioral sensitization of motor activity in the MPTP-treated common marmoset as a Parkinson's disease model.

  2014cites this paper
• Affinity of dihydropyrimidone analogues for adenosine A1 and A2A receptors

  2014influential citation
• Potencial terapêutico das fenilcromonascarboxamidas

  2014cites this paper
• Adenosine (A)(2A)receptor modulation of nicotine-induced locomotor sensitization. A pharmacological and transgenic approach.

  2014cites this paper
• Potential role of G protein-coupled receptor (GPCR) heterodimerization in neuropsychiatric disorders: A focus on depression

  2013cites this paper
• Effects of cocaine self‐administration and extinction on D2‐like and A2A receptor recognition and D2‐like/Gi protein coupling in rat striatum

  2013cites this paper
• An overview of the diverse roles of G-protein coupled receptors (GPCRs) in the pathophysiology of various human diseases.

  2013cites this paper
• G protein-coupled receptor heterocomplexes in neuropsychiatric disorders.

  2013cites this paper
• Adenosine-Dopamine Interactions in the Open Field Arena: Studies Related to Locomotion and Anxiety

  2012cites this paper
• Role of CaMKII and the GluN2B subunit of the NMDAR in dorsal striatal glutamatergic synaptic transmission, MSN morphology and striatal-based behaviors

  2012cites this paper
• A(2A)/D(2) receptor heteromerization in a model of Parkinson's disease. Focus on striatal aminoacidergic signaling.

  2012cites this paper
• A new D₂ dopamine receptor agonist allosterically modulates A(2A) adenosine receptor signalling by interacting with the A(2A)/D₂ receptor heteromer.

  2012cites this paper
• RGS4 is required for dopaminergic control of striatal LTD and susceptibility to parkinsonian motor deficits.

  2012cites this paper
• PET studies in Parkinson's disease dyskinesias and dementia

  2012cites this paper
• Parkinson's Disease Therapeutics: New Developments and Challenges Since the Introduction of Levodopa

  2012cites this paper
• Oligomerization of G-Protein-Coupled Receptors

  2012cites this paper
• A novel conjugated agent between dopamine and an A2A adenosine receptor antagonist as a potential anti-Parkinson multitarget approach.

  2012cites this paper
• Deuterium-L-DOPA: a Novel Means to Improve Treatment of Parkinson's Disease

  2012cites this paper
• Pathophysiology of GPCR Homo- and Heterodimerization: Special Emphasis on Somatostatin Receptors

  2012cites this paper
• Control of Striatal Signaling by G Protein Regulators

  2011cites this paper